Search for: "Apotex Pharmaceutical Holdings Inc."
Results 1 - 20 of 58
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
16 Dec, 2008 5:16 am by Donald Zuhn
By Kevin E. Noonan --Denial of an ANDA validity challenge by generic pharmaceutical company Apotex of Sanofi-Synthelabo's Orange Book-listed patent for Plavix® was affirmed by the Federal Circuit last week. The decision, ... particular brand of mischief on U.S. patent law. Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. § 271(e)(4) in response to a Paragraph IV certification submitted ...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
19 Jun, 2007 12:08 pm by Stephen Albainy-Jenei
... mineral bases, or one of the two enantiomers or their mixture and a pharmaceutically acceptable carrier. In the end, the court held that: Apotex's argument, however, is ultimately unpersuasive. First, it is undisputed that ... disclose all species within that broad category." Metabolite Labs., Inc. v. Lab. Corp. of Am. Holdings, 370 F.3d 1354, 1367 (Fed. Cir. ... not unexpected and urged that the recent decision of the Federal Circuit, Pfizer, Inc. v. Apotex, 480 F.3d 1348 (Fed. Cir. 2007), would yield ...
Tags: Litigation, IP
Patent Baristas - http://www.patentbaristas.com/
15 Jun, 2007 8:11 am by Jake Ward
... of a class of compounds referred to as dihydropyridines. Active drug molecules, such as amlodipine, are frequently made into pharmaceutically-acceptable acid addition salts to improve their bioavailability. Amlodipine besylate is an acid addition salt form of amlodipine, ... have had a reasonable expectation of success in doing so. . . . A reasonable fact-finder could only conclude that Apotex has shown by clear and convincing evidence that the skilled artisan would indeed have been so motivated to ...
ANTICIPATETHIS.com - http://anticipatethis.wordpress.com
13 Sep, 2007 3:57 am by Bill Heinze
In Daiichi Sankyo Co., LTD v. Apotex, Inc., et al. (reissued as a precedential opinion on Septmembr 12, 2006), the Federal Circuit looked to the experience of the inventors to hold that prior art publication directed at "a ... '741 patent's inventors. Accordingly, the level of ordinary skill in the art of the '741 patent is that of a person engaged in developing pharmaceutical formulations and treatment methods for the ear or a specialist in ear treatments such as an otologist, otolaryngologist, or ...
I/P Updates - http://ip-updates.blogspot.com
28 Apr, 2008 11:00 am
... dismisses impeachment proceeding as moot: AB Hassle v Apotex: (Gowlings), Metadate (Methylphenidate) - US: UCB launches patent infringement lawsuit against KV Pharmaceutical over generic Metadate: (IP Law360), Monistat (Miconazole) - US: Johnson & Johnson subsidiary files ... affirms ITC ruling holding Energizer patent for mercury-free batteries invalid: Energizer Holdings, Inc v Int'l Trade Commission: (IP Law360), (Hal Wegner), (Patent Prospector), Facebook - C E Harris ...
IP Thinktank - http://duncanbucknell.com/blog
9 Apr 7:52 am
... EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi ... Myers Squibb v Apotex (Pharmacapsules @ Gowlings) OxyContin (Oxycodone) - UK: EWHC: Sustained release OxyContin patent sustained: Napp Pharmaceutical Holdings Ltd v ratiopharm ... Holdings Ltd v Sandoz Ltd (Hal Wegner) (IPKat) (Law360) Plavix (Clopidogrel) - US: Former Bristol-Myers Squibb senior executive pleads guilty for role ...
IP Thinktank - http://duncanbucknell.com/blog
17 Jan, 2008 10:00 pm
... Generic Pharmaceuticals & IP), (IP Law360), (Reuters), Miacalcin (Calcitonin) - 30 day stay for Miacalcin patent infringement case so Novartis and Apotex can ... no inequitable conduct by Purdue in antitrust litigation: (Patent Docs), Saquinavir - Roche Holding AG entering into four new cost-free technology transfers with local ... other cellular tech companies: (IP Law360), Diomed Holding Inc - Federal Judge rejects bid by Diomed to hold AngioDynamics and Vascular Solutions in contempt for continuing ...
IP Thinktank - http://duncanbucknell.com/blog
15 Jan, 2008 3:06 am
... it to Pacer until after January 1. 1:07-cv-00369 Induction Holding Company, LLC v. Ajax Tocco Magnethermic Corporation filed 01/19/07 ... et al filed 05/11/07 1:07-cv-02690 DMS Holdings, Inc. v. Sorensen Research and Development Trust et al filed 05/11 ... 10/02/07 1:07-cv-04050 Ortho-McNeil Pharmaceutical, Inc. v. Apotex, Inc. filed 07/18/07 1:07-cv-04062 Nike, ... 07-cv-04709 International Securities Exchange , LLC v. Chicago Board Options Exchange, Inc. filed 08/20/07 1:07-cv-04729 Niro, Scavone, Haller ...
Chicago IP Litigation Blog - http://www.chicagoiplitigation.com/
2 Aug, 2008 12:54 am
... industrial application: Eli Lilly & Co v Human Genome Sciences Inc; (IPKat), US: FDA seeks input on FDCA § 301(ll) prohibition on introducing ... US: Celgene wins bid to have Buchanan Ingersoll disqualified from representing KV Pharmaceutical in longstanding patent dispute over Ritalin: (Law360), Sensipar (Cincalcet hydrochloride) - US: ... Applicant fails to prove damages in trade mark case Pharmacommunications Holdings Inc v Avencia International Inc: (Canadian Trademark Blog), RIAA v. Almost 30 ...
IP Thinktank - http://duncanbucknell.com/blog
27 Feb 5:00 am
... marketing of Modified Sequential Screening protocol: Intema Ltd v NTD Laboratories, Inc et al (Patent Docs) US: District Court Delaware: Motion to dismiss ... patent infringement following Teva's Para IV certification as part of ANDA for generic Integrilin: Millennium Pharmaceuticals Inc. et al. v. Teva Parenteral Medicines ... ruling holding QLT liable for unfair trade practices, unjust enrichment in patent ownership dispute with Harvard Medical School affiliate (Law360) Zymar (Gatifloxacin) - US: Apotex ...
IP Thinktank - http://duncanbucknell.com/blog
22 Jan 2:06 am by Beck/Herrmann
... 519-20 (2004), another division of the First District rejected a misrepresentation theory that sought to hold a non-manufacturing predecessor corporation liable in an asbestos case. If Cadlo goes by ... v. Teva Pharmaceuticals USA, Inc., 2007 WL 5787186, at *2-3 (S.D. Ala. Apr. 24, 2007); Colacicco v. Apotex, Inc., 432 F ... drug should be better off - with an extra cause of action against a non-manufacturing pharmaceutical company - than an identical plaintiff who took a pioneer drug. Cf. Ramirez, 6 ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
11 Jul, 2008 4:30 am
... Mylan Pharmaceuticals over Azor consolidated with another dispute between the companies over related drug Benicar: (IP Law360), Carbatrol (Carbamazepine) - US: Shire sues Apotex, ... (IP Menu News), Family marks - what is the reach of Google as a trade mark?: Google, Inc v Dmitri Rytsk: (IPRoo), Austal Ships Sales Pty Ltd v ... patent related to hinged-lid container: (IP Law360), Texas Instruments - CAFC holds method claim with specific preamble structure not indefinite: Microprocessor Enhancement Corp ...
IP Thinktank - http://duncanbucknell.com/blog
18 Jul, 2008 8:34 am
... eat into sales of the brand drug?: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), ... ) - US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) - US: Federal judge allows Corepharma to seek DJ that its application to make ...
IP Thinktank - http://duncanbucknell.com/blog
16 Aug, 2008 2:43 am
... (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v ... ), US: Biotech rivals Eppendorf AG and Bio-Rad Lab's Inc drop patent suits against each other over cell-breeding and DNA ... patent lawsuit against Apotex over production of generic Lipitor: (Law360), (GenericsWeb), Naprelan (Naproxen) - US: District Court rules that Watson Pharmaceuticals' generic Naprelan infringes ...
IP Thinktank - http://duncanbucknell.com/blog
23 Aug, 2008 1:23 am
... v Medicis Pharmaceutical Corp: (Patently-O), (Patent Docs), (Patent Prospector), Plavix (Clopidogrel) - Australia: Enantiomer claims fail; salt claims stand: Apotex v ... State Court refuses to stop distribution of film 'Expelled: No Intelligence Allowed' holding that its user of a John Lennon clip is unlikely to violate copyright held by EMI and ... trade mark case Koninklijke Philips Electronics NV v KXD Technology, Inc: (Seattle Trademark Lawyer), Lending Tree - Lending Tree, IMX settle remaining ...
IP Thinktank - http://duncanbucknell.com/blog
29 Feb, 2008 8:00 am
... treatment: (Patent Docs), (Therapeutics Daily), Avodart (Dutasteride) - GlaxoSmithKline files patent suit against Barr Pharmaceuticals Inc., claiming infringement of three patents covering its enlarged-prostate treatment, Avodart; Barr challenges GSK's Avodart ... Ranbaxy is still blocked from launching generic version of the drug: (IP Law360), Neurontin (Gabapentin) - Apotex Corp and Pfizer Inc. settle all outstanding patent infringement and antitrust litigation over Pfizer's blockbuster epilepsy ...
IP Thinktank - http://duncanbucknell.com/blog
8 Feb, 2008 7:00 pm
... reached by Bayer and several generic drug companies violates antitrust laws: (Orange Book Blog), Crestor (Rosuvastatin) - Apotex commences lawsuit against AstraZeneca for blocking a generic version of Crestor: (IP Law360), Cubicin (Daptomycin) - Corrected Cubist patent now relisted in Orange Book: (GenericsWeb) Depakote (Valproate semisodium) - Abbot sues Sun Pharmaceuticals to block generic Depakote: (IP Law360), Enbrel (etanercept ) / Kineret (Anakinra) - Federal judge allows Amgen to add ...
IP Thinktank - http://duncanbucknell.com/blog
5 Aug 5:35 am
... exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb) Biotechnology companies at forefront of global health ... infringed but invalid, dismisses two actions for infringement: Sanofi v Apotex/Novopharm (Pharmacapsules@Gowlings) Altace (Ramipril) - Canada: Court of Appeal upholds decision holding generic company not required to address patents listed ...
IP Thinktank - http://duncanbucknell.com/blog
15 Jul 5:15 am
... ) (Michael Geist) UK: EWHC on what first authorisation means: Generics (UK) v Synaptech Inc (The SPC Blog) US: Follow-on biologics proposals considered by US Senate HELP Committee; ... Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) - Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) - US: Caraco Pharmaceuticals enters into asset purchase agreement with ...
IP Thinktank - http://duncanbucknell.com/blog
1 Oct 2:14 am by Beck/Herrmann
... as an earlier order in the Masterson case - Masterson v. Apotex Corp., 2008 WL 2047979 (S.D. Fla. May 13, 2008), hold that "properly joined and served" under 28 ... v. Eon Labs, Inc., 622 F. Supp.2d 137, 141-42 (D.N.J. 2007); and Simandle (Thompson, supra; Yocham v. Novartis Pharmaceuticals Corp., 2007 ... that the forum defendant be 'joined and served' to preclude removal"); Vitatoe v. Mylan Pharmaceuticals, supra, 2008 WL 3540462. On the other side of the ledger, well, that's usually the plaintiff's ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck